Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib plus Letrozole in Advanced Breast Cancer
NCT02115048Phase 2Terminated
- Sponsor
- Translational Research In Oncology
- Start
- Jul 2014
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of afatinib in breast cancer, sponsored by Translational Research In Oncology. Started Jul 2014; status: terminated.
02
Drugs
afatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02115048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115048.